Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 451-457

  Salendo, Junius ^a   Spitzner, Melanie ^a   Kramer, Frank ^a   Zhang, Xin ^a   Jo, Peter ^a   Wolff, Hendrik A ^a   Kitz, Julia ^a   Kaulfuß, Silke ^a   Beißbarth, Tim ^a   Dobbelstein, Matthias ^a   Ghadimi, Michael ^a   Grade, Marian ^a   Gaedcke, Jochen ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

let 7g; MiR320; MiRNA; Preoperative chemoradiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; MICRORNA; MICRORNA 132; MIRNA 224; MIRNA 320A; MIRNA LET7G; MITOGEN ACTIVATED PROTEIN KINASE; OXALIPLATIN; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PROGNOSIS; CHEMORADIOTHERAPY; CHEMOSENSITIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOSENSITIVITY; RECTUM CANCER; RNA ANALYSIS;

LET-7G; MIR320; MIRNA; PREOPERATIVE CHEMORADIOTHERAPY; RECTAL CANCER;

CELL LINE, TUMOR; CHEMORADIOTHERAPY; COLORECTAL NEOPLASMS; HUMANS; MICRORNAS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84887014918     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.032     Document Type: Article

References (45)

1. P.F. Engstrom, J.P. Arnoletti, and A.B. Benson 3rd NCCN clinical practice guidelines in oncology: rectal cancer J Natl Compr Canc Netw 7 2009 838 881
2. W. Schmiegel, A. Reinacher-Schick, and D. Arnold Update S3-guideline "colorectal cancer" 2008 Z Gastroenterol 46 2008 799 840
3. C. Rodel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
4. K. Haustermans, M. Lambrecht, and A. Debucquoy The ESTRO Breur Lecture 2010: toward a tailored patient approach in rectal cancer Radiother Oncol 100 2011 15 21
5. V. Valentini, R.J. Myerson, and P. Lambin Is it time for tailored treatment of rectal cancer? From prescribing by consensus to prescribing by numbers Radiother Oncol 102 2012 1 3
6. M. Spitzner, G. Emons, and F. Kramer A gene expression signature for chemoradiosensitivity of colorectal cancer cells Int J Radiat Oncol Biol Phys 78 2010 1184 1192
7. M. Esteller Non-coding RNAs in human disease Nat Rev Genet 12 2011 861 874
8. O. Slaby, M. Svoboda, R. Michalek, and J. Vyzula MicroRNAs in colorectal cancer: translation of molecular biology into clinical application Mol Cancer 8 2009 102
9. K.M. Lee, E.J. Choi, and I.A. Kim MicroRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling Radiother Oncol 101 2011 171 176
10. W.Y. Mansour, N.V. Bogdanova, and U. Kasten-Pisula Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma Radiother Oncol 106 2013 147 154
11. M. Grade, A.B. Hummon, and J. Camps A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets Int J Cancer 128 2011 1069 1079
12. E. Kendziorra, K. Ahlborn, and M. Spitzner Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy Carcinogenesis 32 2011 1824 1831
13. M. Grade, B.M. Ghadimi, and S. Varma Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas Cancer Res 66 2006 267 282
14. C. Rodel, T. Liersch, and H. Becker Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 2012 679 687
15. R. Sauer, T. Liersch, and S. Merkel Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 2012 1926 1933
16. G.L. Papadopoulos, P. Alexiou, M. Maragkakis, M. Reczko, and A.G. Hatzigeorgiou DIANA-mirPath: integrating human and mouse microRNAs in pathways Bioinformatics 25 2009 1991 1993
17. J. Gaedcke, M. Grade, and J. Camps The rectal cancer microRNAome - microRNA expression in rectal cancer and matched normal mucosa Clin Cancer Res 18 2012 4919 4930
18. B.M. Bolstad, R.A. Irizarry, T.P. Speed, and M. Astrand A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 19 2003 185 193
19. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 [Article3]
20. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J Roy Statist Soc Ser B 57 1995 289 300
21. A.K. Gupta, V.J. Bakanauskas, W.G. McKenna, E.J. Bernhard, and R.J. Muschel Ras regulation of radioresistance in cell culture Methods Enzymol 333 2001 284 290
22. S.A. Eschrich, J. Pramana, and H. Zhang A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation Int J Radiat Oncol Biol Phys 75 2009 489 496
23. S. Eschrich, H. Zhang, and H. Zhao Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform Int J Radiat Oncol Biol Phys 75 2009 497 505
24. J.M. Mariadason, D. Arango, and Q. Shi Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin Cancer Res 63 2003 8791 8812
25. K. Okamura, M.D. Phillips, and D.M. Tyler The regulatory activity of microRNA species has substantial influence on microRNA and 3′ UTR evolution Nat Struct Mol Biol 15 2008 354 363
26. J.S. Yang, M.D. Phillips, and D. Betel Widespread regulatory activity of vertebrate microRNA species RNA 17 2011 312 326
27. L. Guo, and Z. Lu The fate of miRNA strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule? PLoS One 5 2010 e11387
28. T. Brabletz, and S. Brabletz The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer? EMBO Rep 11 2010 670 677
29. A.K. Gupta, V.J. Bakanauskas, and G.J. Cerniglia The Ras radiation resistance pathway Cancer Res 61 2001 4278 4282
30. M.L. Slattery, A. Lundgreen, J.S. Herrick, R.K. Wolff, and B.J. Caan Genetic variation in the transforming growth factor-beta signaling pathway and survival after diagnosis with colon and rectal cancer Cancer 117 2011 4175 4183
31. I.A. Kim, S.S. Bae, and A. Fernandes Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines Cancer Res 65 2005 7902 7910
32. W. Ritchie, J.E. Rasko, and S. Flamant Predicting microRNA targets and functions: traps for the unwary Nat Methods 6 2009 397 398
33. L. Cekaite, and M. Sioud Profiling of miRNA expression and prediction of target genes Methods Mol Biol 629 2010 257 271
34. N. Mencia, E. Selga, V. Noe, and C.J. Ciudad Underexpression of miR-224 in methotrexate resistant human colon cancer cells Biochem Pharmacol 82 2011 1572 1582
35. Y. Wang, A.T. Lee, and J.Z. Ma Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target J Biol Chem 283 2008 13205 13215
36. Z. Liang, H. Wu, and J. Xia Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1 Biochem Pharmacol 79 2010 817 824
37. J.Y. Sun, Y. Huang, and J.P. Li MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin Biochem Biophys Res Commun 420 2012 787 792
38. Y. Zhang, X. He, and Y. Liu MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer Oncol Rep 27 2012 685 694
39. C. Diakos, S. Zhong, and Y. Xiao TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a Blood 116 2010 4885 4893
40. F. Rodel, B. Frey, and W. Leitmann Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models Int J Radiat Oncol Biol Phys 71 2008 247 255
41. H. Arora, R. Qureshi, S. Jin, A.K. Park, and W.Y. Park MiR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1 Exp Mol Med 43 2011 298 304
42. Q. Li, G. Wang, and J.L. Shan MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion J Gastroenterol Hepatol 25 2010 164 171
43. C. Scisciani, S. Vossio, and F. Guerrieri Transcriptional regulation of miR-224 upregulated in human HCCs by NFkappaB inflammatory pathways J Hepatol 56 2012 855 861
44. J. Fu, W. Tang, and P. Du Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis BMC Syst Biol 6 2012 68
45. K. Bujko, M. Kolodziejczyk, and A. Nasierowska-Guttmejer Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation Radiother Oncol 95 2010 298 302